Leerink Partners Starts I-Mab (IMAB) at Outperform
Tweet
Share
E-mailGet Alerts IMAB Hot Sheet
Price: $4.63 --0%
Rating Summary:
14 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 17 | New: 21
Rating Summary:
14 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 17 | New: 21
Join SI Premium – FREE
Leerink Partners initiates coverage on I-Mab (NASDAQ: IMAB) with a Outperform rating and a price target of $9.00.
For an analyst ratings summary and ratings history on I-Mab click here. For more ratings news on I-Mab click here.
Shares of I-Mab closed at $4.13 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Starts Integra LifeSciences (IART) at Neutral
- Amazon.com (AMZN) PT Lowered to $305 at UBS
- UBS Assumes Intuitive Surgical (ISRG) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
